Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HIPEC with Paclitaxel in Locally Advanced Gastric Cancer
NCT02356276Phase 3Unknown
- Sponsor
- Cancer Center of Guangzhou Medical University
- Start
- May 2015
- Primary completion
- Jan 2022
- Modality
- Cytokines & Interferons, Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 3 trial of Paclitaxel Micelles for Injection in gastric cancer (GC), sponsored by Cancer Center of Guangzhou Medical University. Status: unknown.
02
Drugs
Paclitaxel Micelles for Injection
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT02356276.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02356276.